102767-28-2 Levetiracetam - Watsonnoke Scientific Ltd

Identification
Properties
Safety Data
Specifications & Other Information
Links

Identification

CAS Number

102767-28-2

Name

Levetiracetam

Synonyms

(-)-(S)-α-Ethyl-2-oxo-1-pyrrolidineacetamide
(2S)-2-(2-Oxo-1-pyrrolidinyl)butanamid [German] [ACD/IUPAC Name]
(2S)-2-(2-Oxo-1-pyrrolidinyl)butanamide [ACD/IUPAC Name]
(2S)-2-(2-Oxo-1-pyrrolidinyl)butanamide [French] [ACD/IUPAC Name]
(2S)-2-(2-Oxopyrrolidin-1-yl)butanamid [German]
(2S)-2-(2-Oxopyrrolidin-1-yl)butanamide
(aS)-a-Ethyl-2-oxo-1-pyrrolidineacetamide
(S)-Etiracetam
102767-28-2 [RN]
1-pyrrolidineacetamide, a-ethyl-2-oxo-, (aS)-
1-Pyrrolidineacetamide, α-ethyl-2-oxo-, (αS)- [ACD/Index Name]
2(S)-(2-oxopyrrolidin-1-yl)butyramide
44YRR34555
6450
Etiracetam levo-isomer
KEPPRA [Trade name]
Keppra XR
levetiracetam [Spanish] [INN]
Levetiracetam [INN] [Wiki]
lévétiracétam [French] [INN]
levetiracetamum [Latin] [INN]
levetiracetamum
SIB S1
SIB-S1
ucb L059
леветирацетам [Russian] [INN]
ليفيتيراسيتام [Arabic] [INN]
左乙拉西坦 [Chinese] [INN]
(2S)-(2-Oxopyrrolidin-1-yl)butyramide
(2S)-2-(2-ketopyrrolidin-1-yl)butyramide
(2S)-2-(2-oxidanylidenepyrrolidin-1-yl)butanamide
(2S)-2-(2-oxopyrrolidinyl)butanamide
(Î±S)-Î±-Ethyl-2-oxo-1-pyrrolidineacetamide
(S)-(-)-α-ethyl-2-oxo-1-pyrrolidineacetamide
(S)-2-(2-Oxo-1-pyrrolidinyl)butanamide
(s)-2-(2-oxopyrrolidin-1-yl)butanamide
(S)-2-(2-Oxo-pyrrolidin-1-yl)-butyramide
(S)-α-Ethyl-2-oxo-1-pyrrolidineacetamide
(αS)-α-Ethyl-2-oxo-1-pyrrolidineacetamide
[102767-28-2]
1-Pyrrolidineacetamide, α-ethyl-2-oxo-, (S)-
1-pyrrolidineacetamide, α-ethyl-2-oxo-, (αS)
2-((S)-2-Oxo-pyrrolidin-1-yl)-butyramide
2-(2-oxopyrrolidin-1-yl)butanamide
33996-58-6 [RN]
BR-72955
Etiracetam [INN] [Wiki]
etiracetam|levetiracetam
Keppra®
Keppra®|Spritam®|UCB L059|UCB-L 059
Keppra;UCB-L059;UCB L059
Levetiracetam 1.0 mg/ml in Methanol
Levetiracetam; Levetiracetame; Levetiracetamum
Levetiracetam-d6
Levetiracetame
Levetiractam
MFCD03265610 [MDL number]
MFCD11506601 [MDL number]
MLS000759403
OR-2949
Pharmakon1600-01502265
SMR000466303
Spritam®
TL8000131
Torleva
UCB-22059
UCB-L 059
UCB-L059
UNII:44YRR34555
UNII-230447L0GL
UNII-44YRR34555
UX9656166

Molecular Structure

Structure of Levetiracetam CAS 102767-28-2

SMILES

CC[C@@H](C(=O)N)N1CCCC1=O

StdInChI

InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1

StdInChIKey

HPHUVLMMVZITSG-LURJTMIESA-N

Molecular Formula

C8H14N2O2

Molecular Weight

170.21

MDL Number

MFCD03265610

Safety Data

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

RIDADR

NONH for all modes of transport

Specifications and Other Information of Our Levetiracetam CAS 102767-28-2

Standard

EP, USP

GMP

LCFDA

Basic Patent Situation

US expiry date	20050514
EU expiry date	20050514 (20100514)
JP expiry date	20050514

Package

According to customer requirements to packaging

Storage

Under the room temperature and away from light

Application

Used as the Anti-epileptic